产品编号:C183462
产品规格:10mg
产品价格:面议
| 标准品编号: | C183462 |
| 名称: | Carfilzomib-d8 |
| 别名: | (αS)-α-[[2-(4-Morpholinyl)acetyl]amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyl-2-oxiranyl]carbonyl]butyl]-L-phenylalaninamide-d8; (αS)-α-[(4-Morpholinylacetyl)amino]benzenebutanoyl-L-leucyl-N-[(1S)-3-methyl-1-[[(2R)-2-methyloxiranyl]carbonyl]butyl]-L-phenylalaninamide-d8; PR 171-d8; |
| CAS号: | 1537187-53-3 |
| 参考CAS: | 未标记:868540-17-4 |
| 分子式: | C₄₀H₄₉D₈N₅O₇ |
| 分子量: | 727.96 |
| 类别: | Standards; Isotopic Labeled Analogues; Pharmaceutical/API Drug Impurities/Metabolites; |
| 应用: | Carfilzomib-d8, is the labeled analogue of Carfilzomib (C183460), which is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma. |
| 参考文献 | |